Dr. Michael Pollastri earned his bachelor’s degree from the College of the Holy Cross, a master’s degree from Duke University (with Prof. Ned Porter), and his doctorate from Brown University (with Prof. Kathlyn Parker). Following completion of his master’s degree in 1998, he joined Pfizer Global Research & Development, earning his PhD while moving up the ranks within the medicinal chemistry organization, eventually leading the Chemical Technologies group at the Research Technology Center in Cambridge, MA. He remained with Pfizer until 2007, when he accepted a research faculty position in the Boston University Department of Chemistry.There, he led the establishment of the Center for Molecular Discovery, a University resource that encompassed a combination of high-throughput screening and medicinal chemistry optimization capabilities. In 2009, he joined the faculty in the Department of Chemistry and Chemical Biology at Northeastern University, where his research has focused on the discovery of new therapeutics for neglected tropical diseases. He was appointed department chair in 2016 and promoted to full professor in 2017. In addition, he presently serves as the interim director of the Barnett Institute of Chemical and Biological Analysis.